- Home
- VNDA vs CURV Comparison
VNDA vs CURV Comparison
Compare VNDA & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- CURV
- Stock Information
- Founded
- VNDA 2002
- CURV 2001
- Country
- VNDA United States
- CURV United States
- Employees
- VNDA N/A
- CURV N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- CURV Clothing/Shoe/Accessory Stores
- Sector
- VNDA Health Care
- CURV Consumer Discretionary
- Exchange
- VNDA Nasdaq
- CURV Nasdaq
- Market Cap
- VNDA 261.7M
- CURV 307.0M
- IPO Year
- VNDA 2006
- CURV 2021
- Fundamental
- Price
- VNDA $4.78
- CURV $3.03
- Analyst Decision
- VNDA Strong Buy
- CURV Hold
- Analyst Count
- VNDA 3
- CURV 4
- Target Price
- VNDA $15.33
- CURV $5.00
- AVG Volume (30 Days)
- VNDA 408.4K
- CURV 1.1M
- Earning Date
- VNDA 07-30-2025
- CURV 09-03-2025
- Dividend Yield
- VNDA N/A
- CURV N/A
- EPS Growth
- VNDA N/A
- CURV N/A
- EPS
- VNDA N/A
- CURV 0.09
- Revenue
- VNDA $201,351,000.00
- CURV $1,089,931,000.00
- Revenue This Year
- VNDA $16.86
- CURV N/A
- Revenue Next Year
- VNDA $39.78
- CURV N/A
- P/E Ratio
- VNDA N/A
- CURV $32.92
- Revenue Growth
- VNDA 13.37
- CURV N/A
- 52 Week Low
- VNDA $3.81
- CURV $2.18
- 52 Week High
- VNDA $6.37
- CURV $9.14
- Technical
- Relative Strength Index (RSI)
- VNDA 53.88
- CURV 31.60
- Support Level
- VNDA $4.85
- CURV $2.62
- Resistance Level
- VNDA $5.12
- CURV $2.94
- Average True Range (ATR)
- VNDA 0.18
- CURV 0.22
- MACD
- VNDA 0.01
- CURV -0.03
- Stochastic Oscillator
- VNDA 54.05
- CURV 16.08
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.